SynthesisCardiology2026
The Overlay of Cervical Cancer with Cardiac Metastasis.
Synthesis in Cardiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionCervical cancer ranks first for cancer-related deaths among women. Having metastasis to the heart from the cervical cancer holds a poor prognosis with average survival being under 6 months. This metastasis is an understudied phenomenon. For this crossroad of gynecological oncology and cardio-oncology, this scoping review maps the available evidence on cervical cancer with cardiac metastasis to better understand how, when, where cervical cancer spreads in the heart and what can be done with current diagnostic and treatment modalities.
methodsA scoping review was conducted in accordance with PRISMA-ScR guidelines with 41 case reports published between 1965 and 2025 globally were included through systematic search using PubMed and Google Scholar. Data on histologic subtype, time of metastasis, clinical symptoms, echocardiogram findings, and treatment modalities and outcomes were extracted and studied.
resultsThe women aged between 40 and 60 years. Squamous cell carcinoma was the most common subtype of cervical cancer. Cardiac metastasis primarily involved the right ventricle followed by the right atrium, interventricular septum and pericardium. Asymptomatic presentations delayed clinical recognition of metastasis while symptomatic findings led to a misdiagnosis. Echocardiography, MRI, and PET-CT played important diagnostic roles. Treatments included chemotherapy, radiotherapy, immunotherapy, and surgical excision; however, after intervention, prognosis remained poor, with death in most cases within 6-9 months.
conclusionThis review emphasizes the need for heightened clinical suspicion of cardiac metastasis in patients with advanced or recurrent cervical cancer presenting with cardiac symptoms. Timely detection and treatment may improve clinical outcomes in patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.